Gut

International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update

By Maria Mironova, Vlad Ratziu, Mary Eugenia Rinella, Rohit Seth Loomba

ReviewInterventions

The paper

Maria Mironova, Vlad Ratziu, Mary Eugenia Rinella, Rohit Seth Loomba

University of California San Diego

Gut, 11 Sep 2026

doi.org/10.1136/gutjnl-2026-340031 PubMed 42728029

Nature Metabolism2 Oct 2026
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs